Our earlier work reported DER in a nonmetastatic squamous cell carcinoma (SCC) murine model that showed improved radiation-induced tumor growth delay by the pan-NOS inhibitor L-NAME (DER 1.8), which involved abated IL-10 expression and increased CD8+ T cell number and activation (7). Here, IL10 is linked to squamous cell carcinoma.